Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3072% below fair value
$174.51+4.81 (+2.83%)
Close on Nov 17, 2026Market cap $1.20BP/E 6.9Yield –
Nutex Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nutex Health's revenue for the twelve months ending Jun 30, 2026 was $846.72M, up 6.9% year over year. For fiscal 2025 it was $875.26M, up 82.4% from the year before. Over ten years it grew 112.1% a year on average. The highest annual figure on record is $875.26M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $875.26M | +82.4% |
| FY2024 | Dec 31, 2024 | $479.95M | +93.8% |
| FY2023 | Dec 31, 2023 | $247.65M | +12.9% |
| FY2022 | Dec 31, 2022 | $219.29M | -33.9% |
| FY2021 | Dec 31, 2021 | $331.53M | +21.0% |
| FY2020 | Dec 31, 2020 | $274.03M | +19954.5% |
| FY2019 | Dec 31, 2019 | $1.37M | -0.0% |
| FY2018 | Dec 31, 2018 | $1.37M | +5800.9% |
| FY2017 | Dec 31, 2017 | $23.17K | – |
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $474.68K | -55.6% |
| FY2014 | Dec 31, 2014 | $1.07M | -26.9% |
| FY2013 | Dec 31, 2013 | $1.46M | -8.3% |
| FY2012 | Dec 31, 2012 | $1.59M | -10.7% |
| FY2011 | Dec 31, 2011 | $1.78M | +103.9% |
| FY2010 | Dec 31, 2010 | $874.77K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $210.75M | -13.6% |
| Q1 FY2026 | Mar 31, 2026 | $216.49M | +2.2% |
| Q4 FY2025 | Dec 31, 2025 | $151.68M | -41.1% |
| Q3 FY2025 | Sep 30, 2025 | $267.80M | +239.9% |
| Q2 FY2025 | Jun 30, 2025 | $243.99M | +220.7% |
| Q1 FY2025 | Mar 31, 2025 | $211.79M | +214.0% |
| Q4 FY2024 | Dec 31, 2024 | $257.62M | +269.8% |
| Q3 FY2024 | Sep 30, 2024 | $78.80M | +25.6% |
| Q2 FY2024 | Jun 30, 2024 | $76.08M | +29.1% |
| Q1 FY2024 | Mar 31, 2024 | $67.45M | +19.7% |
| Q4 FY2023 | Dec 31, 2023 | $69.67M | +29.7% |
| Q3 FY2023 | Sep 30, 2023 | $62.72M | +120.9% |
| Q2 FY2023 | Jun 30, 2023 | $58.92M | +1.5% |
| Q1 FY2023 | Mar 31, 2023 | $56.33M | -28.8% |
| Q4 FY2022 | Dec 31, 2022 | $53.72M | -15.3% |
| Q3 FY2022 | Sep 30, 2022 | $28.40M | -75.9% |
| Q2 FY2022 | Jun 30, 2022 | $58.05M | -7.6% |
| Q1 FY2022 | Mar 31, 2022 | $79.13M | +3828.2% |
| Q4 FY2021 | Dec 31, 2021 | $63.40M | -76.8% |
| Q3 FY2021 | Sep 30, 2021 | $117.97M | +33603.1% |
| Q2 FY2021 | Jun 30, 2021 | $62.81M | +16491.8% |
| Q1 FY2021 | Mar 31, 2021 | $2.01M | +332.6% |
| Q4 FY2020 | Dec 31, 2020 | $272.83M | +52939.7% |
| Q3 FY2020 | Sep 30, 2020 | $350.03K | +79.9% |
| Q2 FY2020 | Jun 30, 2020 | $378.59K | -15.0% |
| Q1 FY2020 | Mar 31, 2020 | $465.63K | +119.5% |
| Q4 FY2019 | Dec 31, 2019 | $514.40K | -61.5% |
| Q3 FY2019 | Sep 30, 2019 | $194.61K | +761.8% |
| Q2 FY2019 | Jun 30, 2019 | $445.28K | +11850.6% |
| Q1 FY2019 | Mar 31, 2019 | $212.14K | +4960.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.34M | +28985.9% |
| Q3 FY2018 | Sep 30, 2018 | $22.58K | +419.1% |
| Q2 FY2018 | Jun 30, 2018 | $3.73K | – |
| Q1 FY2018 | Mar 31, 2018 | $4.19K | – |
| Q2 FY2017 | Jun 30, 2017 | $4.60K | – |
| Q1 FY2017 | Mar 31, 2017 | $4.35K | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
| Q2 FY2016 | Jun 30, 2016 | $0 | – |
See a number that looks wrong?